Systemic administration of doxorubicin impairs aversively motivated memory in rats

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 2, 2009, Pages 239-243

  Liedke, Pedro Emanuel Rubini ^a,b   Reolon, Gustavo Kellermann ^a,b   Kilpp, Bruno ^a,b   Brunetto, Algemir Lunardi ^b,c   Roesler, Rafael ^a,b   Schwartsmann, Gilberto ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Instituto do Cérebro do Rio Grande do Sul InsCer   (Brazil)

Author keywords

Amygdala; Chemo brain; Chemo fog; Cognitive impairment; Doxorubicin; Hippocampus; Inhibitory avoidance; Memory; Rats

Indexed keywords

DOXORUBICIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; EXPLORATORY BEHAVIOR; LONG TERM MEMORY; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOTIVATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; REARING; SINGLE DRUG DOSE; SYSTEMIC THERAPY;

ANIMALS; AVOIDANCE LEARNING; DOXORUBICIN; MALE; MEMORY; MOTIVATION; RATS; RATS, WISTAR; REACTION TIME;

RATTUS;

EID: 72049120388     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.09.001     Document Type: Article

References (25)

1. Ahles T.A., and Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7 (2007) 192-201
2. Ahles T.A., Saykin A.J., Furstenberg C.T., Cole B., Mott L.A., Skalla K., et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20 (2002) 485-493
3. Bianchin M.M., Spanis C.W., Roesler R., McGaugh J.L., and Izquierdo I. (+/-)-Alpha-methyl-4-carboxyphenylglycine, a metabotropic glutamate receptor blocker, impairs retention of an inhibitory avoidance task in rats when infused into the basolateral nucleus of the amygdala. Brain Res 852 (2000) 436-443
4. Brezden C.B., Phillips K.-A., Abdolell M., Bunston T., and Tannock I.F. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18 (2000) 2695-2701
5. Danesi R., Fogli S., Gennari A., Conte P.A., and Del Tacca M. Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet 41 (2002) 431-444
6. Falleti M.G., Sanfilippo A., Maruff P., Weih L., and Phillips K.-A. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59 (2005) 60-70
7. Fan H.G.M., Houede-Tchen N., Yi Q.-L., Chemerynsky I., Downie F.P., Sabate K., et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23 (2005) 8025-8032
8. Food and Drug Administration. (2007). "FDA dose calculator." Oncology Tools Retrieved 12/10/2007, 2007, from http://www.fda.gov/cder/cancer/animalframe.htm.
9. Henderson N.D., Turri M.G., DeFries J.C., and Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet 34 (2004) 267-293
10. Izquierdo I., and Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 68 (1997) 285-316
11. Lee G.D., Longo D.L., Wang Y., Rifkind J.M., Abdul-Raman L., Mamczarz J.A., et al. Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy. Clin Cancer Res 12 (2006) 198-205
12. MacLeod J.E., DeLeo J.A., Hickey W.F., Ahles T.A., Saykin A.J., and Bucci D.J. Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav Brain Res 181 (2007) 168-172
13. Maidana M., Carlis V., Galhardi F.G., Yunes J.S., Geracitano L.A., Monserrat J.M., et al. Effects of microcystins over short- and long-term memory and oxidative stress generation in hippocampus of rats. Chemico Biol Interact 159 (2006) 223-234
14. Picada J.N., Schröder N., Izquierdo I., Henriques J.A., and Roesler R. Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats. Eur J Pharmacol 443 (2002) 105-111
15. Quevedo J., Vianna M.R., Martins M.R., Barichello T., Medina J.H., Roesler R., et al. Protein synthesis, PKA, and MAP kinase are differentially involved in short- and long-term memory in rats. Behav Brain Res 154 (2004) 339-343
16. Reiriz A.B., Reolon G.K., Preissler T., Rosado J.O., Roesler R., and Schwartsmann G. Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res 12 (2006) 5000-5001
17. Schagen S.B., Hamburger H.L., Muller M.J., Boogerd W., and van Dam F.S.A.M. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 51 (2001) 159-165
18. Schroder N., de Lima M.N.M., Quevedo J., Dal Pizzol F., and Roesler R. Impairing effects of chronic haloperidol and clozapine treatment on recognition memory: possible relation to oxidative stress. Schizophr Res 73 (2005) 377-378
19. Seigers R., Schagen S.B., Beerling W., Boogerd W., van Tellingen O., van Dam F.S.A.M., et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 186 (2008) 168-175
20. Silverman D.H.S., Dy C.J., Castellon S.A., Lai J., Pio B.S., Abraham L., et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat (2006) 10.1007/s10549-006-9380-z Published Online Sept 29
21. Tannock I.F., Ahles T.A., Ganz P.A., and van Dam F.S. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J Clin Oncol 22 (2004) 2233-2239
22. Taubenfeld S.M., Wiig K.A., Bear M.F., and Alberini C.M. A molecular correlate of memory and amnesia in the hippocampus. Nat Neurosci 2 (1999) 309-310
23. Tchen N., Juffs H.G., Downie F.P., Yi Q.-L., Hu H., Chemerynsky I., et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21 (2003) 4175-4183
24. Van Dam F.S.A.M., Schagen S.B., Muller M.J., Boogerd W., Evd W., Fortuyn M.E.D., et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90 (1998) 210-218
25. Winocur G., Vardy J., Binns M.A., Kerr L., and Tannock I. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 85 (2006) 66-75